Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2017, Article ID 5415243, 8 pages
https://doi.org/10.1155/2017/5415243
Case Report

Rapid Ascending Sensorimotor Paralysis, Hearing Loss, and Fatal Arrhythmia in a Multimorbid Patient due to an Accidental Overdose of Fluoxetine

White Memorial Medical Center Department of Internal Medicine, Los Angeles, CA, USA

Correspondence should be addressed to Matthew Herrmann; moc.liamg@7wehttam.nnamrreh

Received 27 April 2017; Revised 29 August 2017; Accepted 10 September 2017; Published 16 October 2017

Academic Editor: Peter Berlit

Copyright © 2017 Matthew Herrmann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. H. Preskorn, H. P. Feighner, C. Y. Stanga, and R. Ross, Antidepressants: Past, Present and Future, 2004, Past, Present and Future.
  2. G. K. Isbister, S. J. Bowe, A. Dawson, and I. M. Whyte, “Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose,” Journal of Toxicology—Clinical Toxicology, vol. 42, no. 3, pp. 277–285, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. N. White, T. Litovitz, and C. Clancy, “Suicidal antidepressant overdoses: a comparative analysis by antidepressant type.,” Journal of medical toxicology : official journal of the American College of Medical Toxicology, vol. 4, no. 4, pp. 238–250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. J. Borys, S. C. Setzer, L. J. Ling, J. J. Reisdorf, L. C. Day, and E. P. Krenzelok, “Acute fluoxetine overdose: A report of 234 cases,” American Journal of Emergency Medicine, vol. 10, no. 2, pp. 115–120, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. M. W. Lai, W. Klein-Schwartz, G. C. Rodgers et al., “2005 Annual report of the American association of poison control centers’ national poisoning and exposure database,” Clinical Toxicology, vol. 44, no. 6-7, pp. 803–932, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. T. Barbey and S. P. Roose, “SSRI safety in overdose,” Journal of Clinical Psychiatry, vol. 59, suppl. 15, pp. 42–48, 1998. View at Google Scholar
  7. H. A. Spiller, S. Morse, and C. Muir, “Fluoxetine ingestion: a one year retrospective study,” Veterinary and Human Toxicology, vol. 32, article 153, 1990. View at Google Scholar
  8. W. Chiang, M. Ford, P. Wax, R. Hoffman, M. Howland, and L. Goldfrank, “Prospective evaluation of fluoxetine ingestions,” Veterinary and Human Toxicology, vol. 32, article 348, 1991. View at Google Scholar
  9. Top 200 generic drugs by unit in 2007. Drug Topics, June 2017, http://drugtopics.modernmedicine.com/drug-topics/news/modernmedicine/modern-medicine-feature-articles/top-200-generic-drugs-unit-2007.
  10. J. J. Weber, “Seizure activity associated with fluoxetine therapy,” The Journal of Clinical Pharmacology, pp. 8:296–8:296, 1989. View at Google Scholar
  11. R. Hargrave, D. Martinez, and A. J. Bernstein, “Fluoxetine-induced seizures,” Psychosomatics, vol. 33, no. 2, pp. 236-237, 1992. View at Publisher · View at Google Scholar · View at Scopus
  12. V. P. Prasher, “Seizures associated with fluoxetine therapy,” Seizure, vol. 2, no. 4, pp. 315–317, 1993. View at Publisher · View at Google Scholar · View at Scopus
  13. M. R. Ware and R. B. Stewart, “Seizures Associated with Fluoxetine Therapy,” DICP, vol. 23, no. 5, pp. 428–428, 2016. View at Publisher · View at Google Scholar
  14. G. Braitberg and S. C. Curry, “Seizure after isolated fluoxetine overdose,” Annals of Emergency Medicine, vol. 26, no. 2, pp. 234–237, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Gross, P. N. Dannon, E. Lepkifker, J. Zohar, and M. Kotler, “Generalized seizures caused by fluoxetine overdose,” American Journal of Emergency Medicine, vol. 16, no. 3, pp. 328-329, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Graudins, C. Vossler, and R. Wang, “Fluoxetine-induced cardiotoxicity with response to bicarbonate therapy,” American Journal of Emergency Medicine, vol. 15, no. 5, pp. 501–503, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Gartlehner, R. A. Hansen, L. C. Morgan et al., “Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: An updated meta-analysis,” Annals of Internal Medicine, vol. 155, no. 11, pp. 772–785, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Elmorsy, A. Al-Ghafari, F. M. Almutairi, A. M. Aggour, and W. G. Carter, “Antidepressants are cytotoxic to rat primary blood brain barrier endothelial cells at high therapeutic concentrations,” Toxicology in Vitro, vol. 44, pp. 154–163, 2017. View at Publisher · View at Google Scholar
  19. A. L. Hansson, Z. Xia, M. C. Berglund, A. Bergstrand, J. W. Depierre, and L. Nässberger, “Reduced cell survival and morphological alterations induced by three tricyclic antidepressants in human peripheral monocytes and lymphocytes and in cell lines derived from these cell types,” Toxicology in Vitro, vol. 11, no. 1-2, pp. 21–31, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. T. S. Davies and W. M. Kluwe, “Erratum: Preclinical toxicological evaluation of sertraline hydrochloride (Drug and Chemical Toxicology),” Drug and Chemical Toxicology, vol. 21, no. 4, pp. 521–537, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Carvajal Garcia-Pando, J. Garcia del Pozo, A. Sanchez et al., “Hepatoxicity associated with new antidepressants,” Journal of Clinical Psychiatry, pp. 135–137, 2002. View at Google Scholar
  22. Y. Li, L. Couch, M. Higuchi, J.-L. Fang, and L. Guo, “Mitochondrial dysfunction induced by sertraline, an antidepressant agent,” Toxicological Sciences, vol. 127, no. 2, pp. 582–591, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Lacy, L. Armstrong, M. P. Goldman, and L. L. Lance, Drug Information Handbook, 20th edition.
  24. http://www.micromedexsolutions.com.
  25. http://www.globalrph.com.